Table 3.
Microbial resistance patterns detected by phenotypic screening among non-typhoidal Salmonella.
| Non-Typhoidal Salmonella | ||||||||
|---|---|---|---|---|---|---|---|---|
| Antibiotic | No. of Resistance Human Isolates | Human Isolates | Resistance Ratio/Human Isolates | No. of Resistance Animal Isolates | Animal Isolates | Resistance Ratio/Animal Isolates | Relative Risk | 95%CI |
| Amoxicillin–Clavulanic acid | 53 | 126 | 42% | 62 | 88 | 70% | 1.09 | [1.01; 1.18] |
| Amoxicillin | 50 | 70 | 71% | 64 | 70 | 91% | 4.02 | [0.16; 103.61] |
| Ampicillin | 97 | 186 | 52% | 96 | 139 | 69% | 1.10 | [0.92; 1.31] |
| Azithromycin | 32 | 75 | 43% | 2 | 22 | 9% | 0.21 | [0.06; 0.82] |
| Cefotaxime | 45 | 145 | 31% | 58 | 92 | 63% | 3 | [0.23; 39.38] |
| Ceftriaxone | 2 | 231 | 1% | 9 | 131 | 7% | 4.33 | [0.93; 20.26] |
| Chloramphenicol | 42 | 281 | 15% | 21 | 181 | 12% | 1.29 | [0.86;1.96] |
| Ciprofloxacin | 26 | 281 | 9% | 30 | 181 | 17% | 1.36 | [0.73; 2.51] |
| Erythromycin | 57 | 57 | 100% | 52 | 52 | 100% | 1 | [0.96; 1.04] |
| Imipenem | 3 | 194 | 2% | 0 | 108 | 0% | 0.45 | [0.05; 4.02] |
| Streptomycin | 50 | 126 | 40% | 38 | 88 | 43% | 1.09 | [0.80; 1.49] |
| Tetracycline | 142 | 231 | 62% | 66 | 131 | 50% | 0.79 | [0.59; 1.06] |
| Trimethoprim–sulfamethoxazole | 67 | 281 | 24% | 15 | 181 | 8% | 0.57 | [0.18; 1.80] |